Intrinsiqq
Nu Skin Enterprises Inc. logo

Nu Skin Enterprises Inc. (NUS) Insider Trading

Last 12 months

Insiders bought $53k and sold $100k on the open market.

82% of the selling was scheduled in advance under 10b5-1 plans.

Net open-market
−$47k
1 buy · 3 sales
Under a 10b5-1 plan
82%
of the value sold
Insiders who bought / sold
1 / 3
executives and directors
Last open-market buy
Nov 2025
Nov 11, 2025

Get an email when NUS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Jun 210b5-1 plan
    James M Winett
    Director · sold 7,203 at $5.62
    $40k
    16% of stake
  • Jun 110b5-1 plan
    Edwina D Woodbury
    Director · sold 7,203 at $5.70
    $41k
    10% of stake
  • May 11No plan
    Laura Nathanson
    Director · sold 2,676 at $6.73
    $18k
    8.1% of stake
  • Nov 11, 2025
    Steven Keith Hatchett
    Chief Product Officer · bought 5,500 at $9.61
    $53k
    3.4% of stake
  • Sep 4, 2025No plan
    Laura Nathanson
    Director · sold 6,489 at $12.22
    $79k
    16% of stake
  • Sep 3, 2025No plan
    Chayce David Clark
    EVP and General Counsel · sold 20,000 at $11.97
    $239k
    7.9% of stake
  • Aug 29, 2025No plan
    Daniel W Campbell
    Director · sold 32,437 at avg $12.11
    $393k
    24% of stake
  • Jun 2, 202510b5-1 plan
    Edwina D Woodbury
    Director · sold 4,532 at $8.44
    $38k
    9.5% of stake
  • Jun 2, 202510b5-1 plan
    Emma S. Battle
    Director · sold 4,532 at $8.44
    $38k
    13% of stake
  • May 28, 2025
    Steven Keith Hatchett
    Chief Product Officer · bought 6,500 at $7.54
    $49k
    4.2% of stake
  • Feb 21, 2025No plan
    Emma S. Battle
    Director · sold 1,693 at $7.73
    $13k
    8.8% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch NUS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Wholesale-Drugs, Proprietaries & Druggists' Sundries

Spot a number that looks wrong? Check it in NUS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing NUS

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.